Mesenchymal Tumors of the Uterus

  • Charles J. Zaloudek
  • Michael R. Hendrickson
  • Robert A. Soslow

Abstract

This chapter deals with neoplasms of the uterus in which there is mesenchymal differentiation. Purely mesenchymal tumors, such as those derived from smooth muscle and endometrial stroma, are considered, as are some benign and malignant neoplasms in which there are mixtures of epithelium and connective tissues. We use a slightly modified version of the comprehensive classification of mesenchymal neoplasms of the uterus, developed by the World Health Organization (WHO; [409]) which is shown in Table 10.1 .

References

  1. 1.
    Abeler VM, Royne O et al (2009) Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology 54(3):355–364PubMedCrossRefGoogle Scholar
  2. 2.
    Abrams J, Talcott J et al (1989) Pulmonary metastases in patients with low-grade endometrial stromal sarcoma. Clinicopathologic findings with immunohistochemical characterization. Am J Surg Pathol 13:133–140PubMedCrossRefGoogle Scholar
  3. 3.
    Abu-Rustum NR, Curtin JP et al (1997) Regression of uterine low-grade smooth-muscle tumors metastatic to the lung after oophorectomy. Obstet Gynecol 89(5 PT 2):850–852PubMedCrossRefGoogle Scholar
  4. 4.
    Adamson GD (1992) Treatment of uterine fibroids: Current findings with gonadotropin-releasing hormone agonists. Am J Obstet Gynecol 166:746–751PubMedGoogle Scholar
  5. 5.
    Adany R, Fodor F et al (1990) Increased density of histiocytes in uterine leiomyomas. Int J Gynecol Pathol 9(2):137–144PubMedCrossRefGoogle Scholar
  6. 6.
    Adegboyega PA, Qiu S (2008) Immunohistochemical profiling of cytokeratin expression by endometrial stroma sarcoma. Hum Pathol 39(10):1459–1464PubMedCrossRefGoogle Scholar
  7. 7.
    Agoff SN, Crispin DA et al (2001) Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study. Mod Pathol 14(3):139–146PubMedCrossRefGoogle Scholar
  8. 8.
    Agoff SN, Grieco VS et al (2001) Immunohistochemical distinction of endometrial stromal sarcoma and cellular leiomyoma. Appl Immunohistochem Mol Morphol 9(2):164–169PubMedCrossRefGoogle Scholar
  9. 9.
    Ali A, Black D et al (2007) Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma. Int J Gynecol Pathol 26(2):115–123PubMedCrossRefGoogle Scholar
  10. 10.
    Altrabulsi B, Malpica A et al (2005) Undifferentiated carcinoma of the endometrium. Am J Surg Pathol 29(10):1316–1321PubMedCrossRefGoogle Scholar
  11. 11.
    Amada S, Nakano H et al (1995) Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific antigens. Int J Gynecol Pathol 14:134–142PubMedCrossRefGoogle Scholar
  12. 12.
    Amant F, De Knijf A et al (2007) Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma. Br J Cancer 97(9):1194–1199PubMedCrossRefGoogle Scholar
  13. 13.
    Amant F, Schurmans K et al (2004) Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma. Gynecol Oncol 93(3):680–685PubMedCrossRefGoogle Scholar
  14. 14.
    Amant F, Steenkiste E et al (2004) Immunohistochemical expression of CD10 antigen in uterine adenosarcoma. Int J Gynecol Cancer 14(6):1118–1121PubMedCrossRefGoogle Scholar
  15. 15.
    Amant F, Woestenborghs H et al (2006) Transition of endometrial stromal sarcoma into high-grade sarcoma. Gynecol Oncol 103(3):1137–1140PubMedCrossRefGoogle Scholar
  16. 16.
    Andersen J (1998) Factors in fibroid growth. Baillières Clin Obstet Gynaecol 12(2):225–243PubMedGoogle Scholar
  17. 17.
    Andrassy RJ, Wiener ES et al (1999) Progress in the surgical management of vaginal rhabdomyosarcoma: a 25-year review from the Intergroup Rhabdomyosarcoma Study Group. J Pediatr Surg 34(5):731–734; discussion 734–735Google Scholar
  18. 18.
    Aozasa K, Saeki K et al (1993) Malignant lymphoma of the uterus. Report of seven cases with immunohistochemical study. Cancer 72(6):1959–1964PubMedCrossRefGoogle Scholar
  19. 19.
    Arenas M, Rovirosa A et al (2006) Uterine sarcomas in breast cancer patients treated with tamoxifen. Int J Gynecol Cancer 16(2):861–865PubMedCrossRefGoogle Scholar
  20. 20.
    Argani P, Antonescu CR et al (2001) Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma – A distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 159(1):179–192PubMedCrossRefGoogle Scholar
  21. 21.
    Argani P, Lal P et al (2003) Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol 27(6):750–761PubMedCrossRefGoogle Scholar
  22. 22.
    Arndt CAS, Donaldson SS et al (2001) What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract? Cancer 91(12):2454–2468PubMedCrossRefGoogle Scholar
  23. 23.
    Atkins KA, Arronte N et al (2008) The use of p16 in enhancing the histologic classification of uterine smooth muscle tumors. Am J Surg Pathol 32(1):98–102PubMedCrossRefGoogle Scholar
  24. 24.
    Aubry MC, Myers JL et al (2002) Endometrial stromal sarcoma metastatic to the lung – a detailed analysis of 16 patients. Am J Surg Pathol 26(4):440–449PubMedCrossRefGoogle Scholar
  25. 25.
    Baiocchi G, Kavanagh JJ et al (1990) Endometrioid stromal sarcomas arising from ovarian and extraovarian endometriosis: report of two cases and review of the literature. Gynecol Oncol 36:147–151PubMedCrossRefGoogle Scholar
  26. 26.
    Baker P, Oliva E (2007) Endometrial stromal tumors of the uterus: a practical approach using conventional morphology and ancillary techniques. J Clin Pathol 60(3):235–243PubMedCrossRefGoogle Scholar
  27. 27.
    Baker PM, Moch H et al (2005) Unusual morphologic features of endometrial stromal tumors: a report of 2 cases. Am J Surg Pathol 29(10):1394–1398PubMedCrossRefGoogle Scholar
  28. 28.
    Baker RJ, Hildebrandt RH et al (1999) Inhibin and CD99 (MIC2) expression in uterine stromal neoplasms with sex-cord-like elements. Hum Pathol 30(6):671–679PubMedCrossRefGoogle Scholar
  29. 29.
    Banks ER, Mills SE et al (1991) Uterine intravascular menstrual endometrium simulating malignancy. Am J Surg Pathol 15:407–412PubMedCrossRefGoogle Scholar
  30. 30.
    Bapat K, Brustein S (1989) Uterine sarcoma with liposarcomatous differentiation: report of a case and review of the literature. Int J Gynaecol Obstet 28:71–75PubMedCrossRefGoogle Scholar
  31. 31.
    Bekkers RL, Willemsen WN et al (1999) Leiomyomatosis peritonealis disseminata: does malignant transformation occur? A literature review. Gynecol Oncol 75(1):158–163PubMedCrossRefGoogle Scholar
  32. 32.
    Bell SW, Kempson RL et al (1994) Problematic uterine smooth muscle neoplasms: a clinicopathologic study of 213 cases. Am J Surg Pathol 18:535–558PubMedCrossRefGoogle Scholar
  33. 33.
    Berchuck A, Rubin SC et al (1988) Treatment of uterine leiomyosarcoma. Obstet Gynecol 71:845–850PubMedGoogle Scholar
  34. 34.
    Bergeron C, Amant F et al (2006) Pathology and physiopathology of adenomyosis. Best Pract Res Clin Obstet Gynaecol 20(4):511–521PubMedCrossRefGoogle Scholar
  35. 35.
    Bhargava R, Shia J et al (2005) Distinction of endometrial stromal sarcomas from “hemangiopericytomatous” tumors using a panel of immunohistochemical stains. Mod Pathol 18(1):40–47PubMedCrossRefGoogle Scholar
  36. 36.
    Biermann K, Heukamp LC et al (2008) Uterine tumor resembling an ovarian sex cord tumor associated with metastasis. Int J Gynecol Pathol 27(1):58–60PubMedCrossRefGoogle Scholar
  37. 37.
    Billings SD, Folpe AL et al (2001) Do leiomyomas of deep soft tissue exist? An analysis of highly differentiated smooth muscle tumors of deep soft tissue supporting two distinct subtypes. Am J Surg Pathol 25(9):1134–1142PubMedCrossRefGoogle Scholar
  38. 38.
    Binder SW, Nieberg RK et al (1991) Histologic and immunohistochemical analysis of nine endometrial stromal tumors: an unexpected high frequency of keratin protein positivity. Int J Gynecol Pathol 10:191–197PubMedCrossRefGoogle Scholar
  39. 39.
    Blattner JM, Gable P et al (2007) Primitive neuroectodermal tumor of the uterus. Gynecol Oncol 106(2):419–422PubMedCrossRefGoogle Scholar
  40. 40.
    Blom R, Guerrieri C (1999) Adenosarcoma of the uterus: a clinicopathologic, DNA flow cytometric, p53 and mdm-2 analysis of 11 cases. Int J Gynecol Cancer 9:37–43PubMedCrossRefGoogle Scholar
  41. 41.
    Blom R, Guerrieri C et al (1998) Leiomyosarcoma of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases. Gynecol Oncol 68:54–61PubMedCrossRefGoogle Scholar
  42. 42.
    Blom R, Malmstrom H et al (1999) Endometrial stromal sarcoma of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 17 cases. Int J Gynecol Cancer 9:98–104PubMedCrossRefGoogle Scholar
  43. 43.
    Bodner K, Bodner-Adler B et al (2004) Estrogen and progesterone receptor expression in patients with uterine smooth muscle tumors. Fertil Steril 81(4):1062–1066PubMedCrossRefGoogle Scholar
  44. 44.
    Bodner-Adler B, Bodner K et al (2005) Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis. Gynecol Oncol 96(1):62–66PubMedCrossRefGoogle Scholar
  45. 45.
    Botsis D, Koliopoulos C et al (2005) Frequency, histological, and immunohistochemical properties of massive inflammatory lymphocytic infiltration of leiomyomas of the uterus: an entity causing diagnostic difficulties. Int J Gynecol Pathol 24(4):326–329PubMedCrossRefGoogle Scholar
  46. 46.
    Brescia RJ, Tazelaar HD et al (1989) Intravascular lipoleiomyomatosis: a report of two cases. Hum Pathol 20:252–256PubMedCrossRefGoogle Scholar
  47. 47.
    Brooks JJ, Wells GB et al (1992) Bizarre epithelioid lipoleiomyoma of the uterus. Int J Gynecol Pathol 11:144–149PubMedCrossRefGoogle Scholar
  48. 48.
    Brooks SE, Zhan M et al (2004) Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989–1999. Gynecol Oncol 93(1):204–208PubMedCrossRefGoogle Scholar
  49. 49.
    Brown DC, Theaker JM et al (1987) Cytokeratin expression in smooth muscle and smooth muscle tumors. Histopathology 11:477–486PubMedCrossRefGoogle Scholar
  50. 50.
    Brunisholz Y, Miller J et al (2004) Endometrial stromal sarcoma resembling adenomyosis and menstrual-phase endometrium. Gynecol Oncol 95(1):256–259PubMedCrossRefGoogle Scholar
  51. 51.
    Bukulmez O, Doody KJ (2006) Clinical features of myomas. Obstet Gynecol Clin N Am 33(1):69–84CrossRefGoogle Scholar
  52. 52.
    Burke C, Hickey K (2004) Treatment of endometrial stromal sarcoma with a gonadotropin-releasing hormone analogue. Obstet Gynecol 104(5 Pt 2):1182–1184PubMedCrossRefGoogle Scholar
  53. 53.
    Cardinale L, Mirra M et al (2008) Angiosarcoma of the uterus: report of 2 new cases with deviant clinicopathologic features and review of the literature. Ann Diagn Pathol 12(3):217–221PubMedCrossRefGoogle Scholar
  54. 54.
    Case AS, Kirby TO et al (2005) A case report of rhabdomyosarcoma of the uterus associated with uterine inversion. Gynecol Oncol 96(3):850–853PubMedCrossRefGoogle Scholar
  55. 55.
    Cessna MH, Zhou H et al (2001) Are myogenin and MyoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics. Am J Surg Pathol 25(9):1150–1157PubMedCrossRefGoogle Scholar
  56. 56.
    Chan JK, Kawar NM et al (2008) Endometrial stromal sarcoma: a population-based analysis. Br J Cancer 99(8):1210–1215PubMedCrossRefGoogle Scholar
  57. 57.
    Chang KL, Crabtree GS et al (1990) Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases. Am J Surg Pathol 14:415–438PubMedCrossRefGoogle Scholar
  58. 58.
    Chang KL, Crabtree GS et al (1993) Primary extrauterine endometrial stromal neoplasms: a clinicopathologic study of 20 cases and a review of the literature. Int J Gynecol Pathol 12:282–296PubMedCrossRefGoogle Scholar
  59. 59.
    Chen KT (1999) Uterine leiomyohibernoma. Int J Gynecol Pathol 18(1):96–97PubMedCrossRefGoogle Scholar
  60. 60.
    Chen L, Yang B (2008) Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors. Int J Gynecol Pathol 27(3):326–332PubMedCrossRefGoogle Scholar
  61. 61.
    Cheung ANY, Ng WF et al (1996) Mixed low grade and high grade endometrial stromal sarcoma of uterus: differences on immunohistochemistry and chromosome in situ hybridisation. J Clin Pathol 49(7):604–607PubMedCrossRefGoogle Scholar
  62. 62.
    Cho KR, Woodruff JD et al (1989) Leiomyoma of the uterus with multiple extrauterine smooth muscle tumors: a case report suggesting multifocal origin. Hum Pathol 20:80–83PubMedCrossRefGoogle Scholar
  63. 63.
    Chu MC, Mor G et al (2003) Low-grade endometrial stromal sarcoma: hormonal aspects. Gynecol Oncol 90(1):170–176PubMedCrossRefGoogle Scholar
  64. 64.
    Chu PG, Arber DA (2000) Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms – Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am J Clin Pathol 113(3):374–382PubMedCrossRefGoogle Scholar
  65. 65.
    Chu PG, Arber DA et al (2001) Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases. Mod Pathol 14(5):465–471PubMedCrossRefGoogle Scholar
  66. 66.
    Chu PW, Liu JY et al (2006) Solitary fibrous tumor of the uterus. Taiwan J Obstet Gynecol 45(4):350–352PubMedCrossRefGoogle Scholar
  67. 67.
    Clement PB (1988) Intravenous leiomyomatosis of the uterus. Pathol Annu 23(Pt 2):153–183PubMedGoogle Scholar
  68. 68.
    Clement PB (1989) Mullerian adenosarcomas of the uterus with sarcomatous overgrowth. A clinicopathological analysis of 10 cases. Am J Surg Pathol 13:28–38PubMedCrossRefGoogle Scholar
  69. 69.
    Clement PB (2000) The pathology of uterine smooth muscle tumors and mixed endometrial stromal-smooth muscle tumors: a selective review with emphasis on recent advances. Int J Gynecol Pathol 19(1):39–55PubMedCrossRefGoogle Scholar
  70. 70.
    Clement PB, Oliva E et al (1996) Mullerian adenosarcoma of the uterine corpus associated with tamoxifen therapy: a report of six cases and a review of tamoxifen-associated endometrial lesions. Int J Gynecol Pathol 15:222–229PubMedCrossRefGoogle Scholar
  71. 71.
    Clement PB, Scully RE (1974) Mullerian adenosarcoma of the uterus. A clinicopathologic analysis of ten cases of a distinctive type of mullerian mixed tumor. Cancer 34:1138–1149PubMedCrossRefGoogle Scholar
  72. 72.
    Clement PB, Scully RE (1976) Uterine tumors resembling ovarian sex-cord tumors. A clinicopathologic analysis of 14 cases. Am J Clin Pathol 66:512–525PubMedGoogle Scholar
  73. 73.
    Clement PB, Scully RE (1978) Extrauterine mesodermal (Mullerian) adenosarcoma: a clinicopathologic analysis of five cases. Am J Clin Pathol 69:276–283PubMedGoogle Scholar
  74. 74.
    Clement PB, Scully RE (1989) Mullerian adenosarcomas of the uterus with sex cord-like elements. A clinicopathologic analysis of eight cases. Am J Clin Pathol 91:664–672PubMedGoogle Scholar
  75. 75.
    Clement PB, Scully RE (1990) Mullerian adenofibroma of the uterus with invasion of myometrium and pelvic veins. Int J Gynecol Pathol 9:363–371PubMedCrossRefGoogle Scholar
  76. 76.
    Clement PB, Scully RE (1990) Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol 21:363–381PubMedCrossRefGoogle Scholar
  77. 77.
    Clement PB, Scully RE (1992) Endometrial stromal sarcomas of the uterus with extensive glandular differentiation: a report of three cases that caused problems in differential diagnosis. Int J Gynecol Pathol 11:163–173PubMedCrossRefGoogle Scholar
  78. 78.
    Clement PB, Young RH et al (1992) Diffuse, perinodular, and other patterns of hydropic degeneration within and adjacent to uterine leiomyomas. Problems in differential diagnosis. Am J Surg Pathol 16:26–32PubMedCrossRefGoogle Scholar
  79. 79.
    Coad JE, Sulaiman RA et al (1997) Perinodular hydropic degeneration of a uterine leiomyoma: a diagnostic challenge. Hum Pathol 28(2):249–251PubMedCrossRefGoogle Scholar
  80. 80.
    Coard KC, Fletcher HM (2002) Leiomyosarcoma of the uterus with a florid intravascular component (“intravenous leiomyosarcomatosis”). Int J Gynecol Pathol 21(2):182–185PubMedCrossRefGoogle Scholar
  81. 81.
    Cohen D, Mazur MT et al (1994) Hyalinization and cellular changes in uterine leiomyomata after gonadotropin releasing hormone agonist therapy. J Reprod Med 39:377–380PubMedGoogle Scholar
  82. 82.
    Cohen DT, Oliva E et al (2007) Uterine smooth-muscle tumors with unusual growth patterns: imaging with pathologic correlation. AJR Am J Roentgenol 188(1):246–255PubMedCrossRefGoogle Scholar
  83. 83.
    Colgan TJ, Pendergast S et al (1993) The histopathology of uterine leiomyomas following treatment with gonadotropin-releasing hormone analogues. Hum Pathol 24:1073–1077PubMedCrossRefGoogle Scholar
  84. 84.
    Coosemans A, Nik SA et al (2007) Upregulation of Wilms' tumour gene 1 (WT1) in uterine sarcomas. Eur J Cancer 43(10):1630–1637PubMedCrossRefGoogle Scholar
  85. 85.
    Cramer SF, Horiszny J et al (1996) The relation of fibrous degeneration to menopausal status in small uterine leiomyomas with evidence for postmenopausal origin of seedling myomas. Mod Pathol 9:774–780PubMedGoogle Scholar
  86. 86.
    Cramer SF, Patel A (1990) The frequency of uterine leiomyomas. Am J Clin Pathol 94:435–438PubMedGoogle Scholar
  87. 87.
    Crist W, Gehan EA et al (1995) The third intergroup rhabdomyosarcoma study. J Clin Oncol 13:610–630PubMedGoogle Scholar
  88. 88.
    Crow J, Gardner RL et al (1995) Morphological changes in uterine leiomyomas treated by GnRH agonist goserelin. Int J Gynecol Pathol 14:235–242PubMedCrossRefGoogle Scholar
  89. 89.
    Crow J, Wilkins M et al (1991) Mast cells in the female genital tract. Int J Gynecol Pathol 10(3):230–237PubMedCrossRefGoogle Scholar
  90. 90.
    Cui S, Hano H et al (1999) Evaluation of new monoclonal anti-MyoD1 and anti-myogenin antibodies for the diagnosis of rhabdomyosarcoma. Pathol Int 49(1):62–68PubMedCrossRefGoogle Scholar
  91. 91.
    Czernobilsky B (2008) Uterine tumors resembling ovarian sex cord tumors: an update. Int J Gynecol Pathol 27(2):229–235PubMedGoogle Scholar
  92. 92.
    Czernobilsky B, Mamet Y et al (2005) Uterine retiform sertoli-leydig cell tumor: report of a case providing additional evidence that uterine tumors resembling ovarian sex cord tumors have a histologic and immunohistochemical phenotype of genuine sex cord tumors. Int J Gynecol Pathol 24(4):335–340PubMedCrossRefGoogle Scholar
  93. 93.
    Dahhan T, Fons G et al (2009) The efficacy of hormonal treatment for residual or recurrent low-grade endometrial stromal sarcoma. A retrospective study. Eur J Obstet Gynecol Reprod Biol 144:80–84PubMedCrossRefGoogle Scholar
  94. 94.
    Dal Cin P, Sayed Aly M et al (1992) Endometrial stromal sarcoma t(7;17)(p15–21;q12–21) is a nonrandom chromosome change. Cancer Genet Cytogenet 63:43–46PubMedCrossRefGoogle Scholar
  95. 95.
    Darby AJ, Papadaki L et al (1975) An unusual leiomyosarcoma of the uterus containing osteoclast-like giant cells. Cancer 36:495–504PubMedCrossRefGoogle Scholar
  96. 96.
    Day Baird D, Dunson DB et al (2003) High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188(1):100–107CrossRefGoogle Scholar
  97. 97.
    Daya D, Lukka H et al (1992) Primitive neuroectodermal tumors of the uterus: a report of four cases. Hum Pathol 23:1120–1129PubMedCrossRefGoogle Scholar
  98. 98.
    Daya DA, Scully RE (1988) Sarcoma botryoides of the uterine cervix in young women: a clinicopathological study of 13 cases. Gynecol Oncol 29:290–304PubMedCrossRefGoogle Scholar
  99. 99.
    De Fusco PA, Gaffey TA et al (1989) Endometrial stromal sarcoma: review of Mayo Clinic experience, 1945–1980. Gynecol Oncol 35:8–14PubMedCrossRefGoogle Scholar
  100. 100.
    de Leval L, Waltregny D et al (2006) Use of histone deacetylase 8 (HDAC8), a new marker of smooth muscle differentiation, in the classification of mesenchymal tumors of the uterus. Am J Surg Pathol 30(3):319–327PubMedGoogle Scholar
  101. 101.
    de Vos S, Wilczynski SP et al (1994) p53 alterations in uterine leiomyosarcomas versus leiomyomas. Gynecol Oncol 54:205–208PubMedCrossRefGoogle Scholar
  102. 102.
    Delahunt B, Eble JN et al (2000) Immunohistochemical evidence for mesothelial origin of paratesticular adenomatoid tumour. Histopathology 36(2):109–115PubMedCrossRefGoogle Scholar
  103. 103.
    Demopoulos RI, Jones KY et al (1997) Histology of leiomyomata in patients treated with leuprolide acetate. Int J Gynecol Pathol 16:131–137PubMedCrossRefGoogle Scholar
  104. 104.
    Devaney K, Tavassoli FA (1991) Immunohistochemistry as a diagnostic aid in the interpretation of unusual mesenchymal tumors of the uterus. Mod Pathol 4:225–231PubMedGoogle Scholar
  105. 105.
    Dgani R, Piura B et al (1998) Clinical-pathological study of uterine leiomyomas with high mitotic activity. Acta Obstet Gynecol Scand 77(1):74–77PubMedGoogle Scholar
  106. 106.
    Dharkar DD, Kraft JR et al (1981) Uterine lipomas. Arch Pathol Lab Med 105:43–45PubMedGoogle Scholar
  107. 107.
    Dimmler A, Seitz G et al (2003) Late pulmonary metastasis in uterine PEComa. J Clin Pathol 56(8):627–628PubMedCrossRefGoogle Scholar
  108. 108.
    Dinh TA, Oliva EA et al (2004) The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990–1999) at the Massachusetts General Hospital. Gynecol Oncol 92(2):648–652PubMedCrossRefGoogle Scholar
  109. 109.
    Dionigi A, Oliva E et al (2002) Endometrial stromal nodules and endometrial stromal tumors with limited infiltration – A clinicopathologic study of 50 cases. Am J Surg Pathol 26(5):567–581PubMedCrossRefGoogle Scholar
  110. 110.
    Downes KA, Hart WR (1997) Bizarre leiomyomas of the uterus: a comprehensive pathologic study of 24 cases with long-term follow-up. Am J Surg Pathol 21(11):1261–1270PubMedCrossRefGoogle Scholar
  111. 111.
    Due W, Pickartz H (1989) Immunohistologic detection of estrogen and progesterone receptors in disseminated peritoneal leiomyomatosis. Int J Gynecol Pathol 8:46–53PubMedCrossRefGoogle Scholar
  112. 112.
    Dueholm M, Lundorf E et al (2002) Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol 186(3):409–415PubMedCrossRefGoogle Scholar
  113. 113.
    Dundr P, Mara M et al (2006) Pathological findings of uterine leiomyomas and adenomyosis following uterine artery embolization. Pathol Res Pract 202(10):721–729PubMedCrossRefGoogle Scholar
  114. 114.
    Eichhorn JH, Young RH et al (2002) Mesodermal (mullerian) adenosarcoma of the ovary: a clinicopathologic analysis of 40 cases and a review of the literature. Am J Surg Pathol 26(10):1243–1258PubMedCrossRefGoogle Scholar
  115. 115.
    Emoto M, Iwasaki H et al (1994) Primary osteosarcoma of the uterus: report of a case with immunohistochemical analysis. Gynecol Oncol 54:385–388PubMedCrossRefGoogle Scholar
  116. 116.
    Euscher ED, Deavers MT et al (2008) Uterine tumors with neuroectodermal differentiation: a series of 17 cases and review of the literature. Am J Surg Pathol 32(2):219–228PubMedCrossRefGoogle Scholar
  117. 117.
    Evans AT III, Symmonds RE et al (1981) Recurrent pelvic intravenous leiomyomatosis. Obstet Gynecol 57:260–264PubMedGoogle Scholar
  118. 118.
    Evans HL (1982) Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma. Cancer 50:2170–2182PubMedCrossRefGoogle Scholar
  119. 119.
    Evans HL, Chawla SP et al (1988) Smooth muscle neoplasms of the uterus other than ordinary leiomyoma. A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors. Cancer 62:2239–2247PubMedCrossRefGoogle Scholar
  120. 120.
    Eyden BP, Hale RJ et al (1992) Cytoskeletal filaments in the smooth muscle cells of uterine leiomyomata and myometrium: an ultrastructural and immunohistochemical analysis. Virchows Archiv A Pathol Anat Histopathol 420:51–58CrossRefGoogle Scholar
  121. 121.
    Fadare O (2008) Perivascular epithelioid cell tumor (PEComa) of the uterus: an outcome-based clinicopathologic analysis of 41 reported cases. Adv Anat Pathol 15(2):63–75PubMedCrossRefGoogle Scholar
  122. 122.
    Fadare O (2008) Uterine PEComa: appraisal of a controversial and increasingly reported mesenchymal neoplasm. Int Semin Surg Oncol 5:7PubMedCrossRefGoogle Scholar
  123. 123.
    Fadare O, Liang SX (2008) Epithelioid smooth muscle tumors of the uterus do not express CD1a: a potential immunohistochemical adjunct in their distinction from uterine perivascular epithelioid cell tumors. Ann Diagn Pathol 12(6):401–405PubMedCrossRefGoogle Scholar
  124. 124.
    Fechner RE (1968) Atypical leiomyomas and synthetic progestogen therapy. Am J Clin Pathol 49:697–703PubMedGoogle Scholar
  125. 125.
    Fehmian C, Jones J et al (1997) Adenosarcoma of the uterus with extensive smooth muscle differentiation: Ultrastructural study and review of the literature. Ultrastruct Pathol 21(1):73–79PubMedCrossRefGoogle Scholar
  126. 126.
    Fekete PS, Vellios F (1984) The clinical and histologic spectrum of endometrial stromal neoplasms: a report of 41 cases. Int J Gynecol Pathol 3:198–212PubMedCrossRefGoogle Scholar
  127. 127.
    Ferguson SE, Gerald W et al (2007) Clinicopathologic features of rhabdomyosarcoma of gynecologic origin in adults. Am J Surg Pathol 31(3):382–389PubMedCrossRefGoogle Scholar
  128. 128.
    Ferguson SE, Tornos C et al (2007) Prognostic features of surgical stage I uterine carcinosarcoma. Am J Surg Pathol 31(11):1653–1661PubMedCrossRefGoogle Scholar
  129. 129.
    Ferrari A, Dileo P et al (2003) Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer 98(3):571–580PubMedCrossRefGoogle Scholar
  130. 130.
    Ferry JA, Harris NL et al (1989) Uterine leiomyomas with lymphoid infiltration simulating lymphoma: a report of seven cases. Int J Gynecol Pathol 8:263–270PubMedCrossRefGoogle Scholar
  131. 131.
    FIGO (2009) FIGO staging for uterine sarcomas. Int J Gynaecol Obstet 104(3):179CrossRefGoogle Scholar
  132. 132.
    Fleming H, Ostor AG et al (1989) Arteriovenous malformations of the uterus. Obstet Gynecol 73:209–214PubMedGoogle Scholar
  133. 133.
    Fleming WP, Peters WA et al (1984) Autopsy findings in patients with uterine sarcoma. Gynecol Oncol 19:168–172PubMedCrossRefGoogle Scholar
  134. 134.
    Flierman PA, Oberye JJ et al (2005) Rapid reduction of leiomyoma volume during treatment with the GnRH antagonist ganirelix. BJOG 112(5):638–642PubMedCrossRefGoogle Scholar
  135. 135.
    Folpe AL, McKenney JK et al (2002) Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma. Am J Surg Pathol 26(9):1175–1183PubMedCrossRefGoogle Scholar
  136. 136.
    Folpe AL, Mentzel T et al (2005) Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol 29(12):1558–1575PubMedCrossRefGoogle Scholar
  137. 137.
    Fornelli A, Pasquinelli G et al (1999) Leiomyoma of the uterus showing skeletal muscle differentiation: A case report. Hum Pathol 30(3):356–359PubMedCrossRefGoogle Scholar
  138. 138.
    Fraggetta F, Magro G et al (1997) Primitive neuroectodermal tumour of the uterus with focal cartilaginous differentiation. Histopathology 30(5):483–485PubMedCrossRefGoogle Scholar
  139. 139.
    Frey NV, Svoboda J et al (2006) Primary lymphomas of the cervix and uterus: the University of Pennsylvania’s experience and a review of the literature. Leuk Lymphoma 47(9):1894–1901PubMedCrossRefGoogle Scholar
  140. 140.
    Fukunaga M (2005) Perivascular epithelioid cell tumor of the uterus: report of four cases. Int J Gynecol Pathol 24(4):341–346PubMedCrossRefGoogle Scholar
  141. 141.
    Fukunaga M, Ishihara A et al (1998) Extrauterine low-grade endometrial stromal sarcoma: report of three cases. Pathol Int 48(4):297–302PubMedCrossRefGoogle Scholar
  142. 142.
    Fukunaga M, Nomura K et al (1996) Carcinosarcoma of the uterus with extensive neuroectodermal differentiation. Histopathology 29(6):565–570PubMedCrossRefGoogle Scholar
  143. 143.
    Fukunaga M, Ushigome S (1998) Dissecting leiomyoma of the uterus with extrauterine extension. Histopathology 32(2):160–164PubMedCrossRefGoogle Scholar
  144. 144.
    Gadducci A, Cosio S et al (2008) The management of patients with uterine sarcoma: a debated clinical challenge. Crit Rev Oncol Hematol 65(2):129–142PubMedCrossRefGoogle Scholar
  145. 145.
    Gadducci A, Landoni F et al (1996) Uterine leiomyosarcoma: analysis of treatment failures and survival. Gynecol Oncol 62:25–32PubMedCrossRefGoogle Scholar
  146. 146.
    Gadducci A, Sartori E et al (1996) Endometrial stromal sarcoma: analysis of treatment failures and survival. Gynecol Oncol 63:247–253PubMedCrossRefGoogle Scholar
  147. 147.
    Gal AA, Brooks JJ et al (1989) Leiomyomatous neoplasms of the lung: a clinical, histologic, and immunohistochemical study. Mod Pathol 2:209–216PubMedGoogle Scholar
  148. 148.
    Gallardo A, Prat J (2009) Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma. Am J Surg Pathol 33(2):278–288PubMedCrossRefGoogle Scholar
  149. 149.
    Gannon BR, Manduch M et al (2008) Differential immunoreactivity of p16 in leiomyosarcomas and leiomyoma variants. Int J Gynecol Pathol 27(1):68–73PubMedCrossRefGoogle Scholar
  150. 150.
    Garcia MG, Deavers MT et al (2006) Myeloid sarcoma involving the gynecologic tract: a report of 11 cases and review of the literature. Am J Clin Pathol 125(5):783–790PubMedCrossRefGoogle Scholar
  151. 151.
    Gard GB, Mulvany NJ et al (1999) Management of uterine leiomyosarcoma in Australia. Aust N Z J Obstet Gynaecol 39(1):93–98PubMedGoogle Scholar
  152. 152.
    Gilks CB, Clement PB et al (2000) Uterine adenomyomas excluding atypical polypoid adenomyomas and adenomyomas of endocervical type: a clinicopathologic study of 30 cases of an underemphasized lesion that may cause diagnostic problems with brief consideration of adenomyomas of other female genital tract sites. Int J Gynecol Pathol 19(3):195–205PubMedCrossRefGoogle Scholar
  153. 153.
    Gilks CB, Taylor GP et al (1987) Inflammatory pseudotumor of the uterus. Int J Gynecol Pathol 6:275–286PubMedCrossRefGoogle Scholar
  154. 154.
    Gisser SD, Young I (1977) Neurilemoma-like uterine myomas: an ultrastructural reaffirmation of their non-Schwannian nature. Am J Obstet Gynecol 129:389–392PubMedGoogle Scholar
  155. 155.
    Giuntoli RL 2nd, Bristow RE (2004) Uterine leiomyosarcoma: present management. Curr Opin Oncol 16(4):324–327PubMedCrossRefGoogle Scholar
  156. 156.
    Giuntoli RL 2nd, Gostout BS et al (2007) Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior. J Reprod Med 52(11):1001–1010PubMedGoogle Scholar
  157. 157.
    Giuntoli RL, Metzinger DS et al (2003) Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol 89(3):460–469PubMedCrossRefGoogle Scholar
  158. 158.
    Goff BA, Rice LW et al (1993) Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence. Gynecol Oncol 50:105–109PubMedCrossRefGoogle Scholar
  159. 159.
    Goh SG, Chuah KL et al (2005) Uterine epithelioid endometrial stromal sarcoma presenting as a “cervical polyp”. Ann Diagn Pathol 9(2):101–105PubMedCrossRefGoogle Scholar
  160. 160.
    Goldberg MF, Hurt WG et al (1977) Leiomyomatosis peritonealis disseminata: report of a case and review of the literature. Obstet Gynecol 49:46s–52sGoogle Scholar
  161. 161.
    Goldblum JR, Clement PB et al (1995) Adenomyosis with sparse glands: a potential mimic of low-grade endometrial stromal sarcoma. Am J Clin Pathol 103:218–223PubMedGoogle Scholar
  162. 162.
    Gollard R, Kosty M et al (1995) Two unusual presentations of mullerian adenosarcoma: case reports, literature review, and treatment considerations. Gynecol Oncol 59(3):412–422PubMedCrossRefGoogle Scholar
  163. 163.
    Gown AM, Boyd HC et al (1988) Smooth muscle cells can express cytokeratins of “simple” epithelium. Immunocytochemical and biochemical studies in vitro and in vivo. Am J Pathol 132:223–232PubMedGoogle Scholar
  164. 164.
    Grayson W, Fourie J et al (1998) Xanthomatous leiomyosarcoma of the uterine cervix. Int J Gynecol Pathol 17:89–90PubMedCrossRefGoogle Scholar
  165. 165.
    Greene LA, Mount SL et al (2003) Recurrent perivascular epithelioid cell tumor of the uterus (PEComa): an immunohistochemical study and review of the literature. Gynecol Oncol 90(3):677–681PubMedCrossRefGoogle Scholar
  166. 166.
    Grignon DJ, Carey MR et al (1987) Diffuse uterine leiomyomatosis: a case study with pregnancy complicated by intrapartum hemorrhage. Obstet Gynecol 69:477–480PubMedGoogle Scholar
  167. 167.
    Gutmann JN, Thornton KL et al (1994) Evaluation of leuprolide acetate treatment on histopathology of uterine myomata. Fertil Steril 61:622–626PubMedGoogle Scholar
  168. 168.
    Gyure KA, Hart WR et al (1995) Lymphangiomyomatosis of the uterus associated with tuberous sclerosis and malignant neoplasia of the female genital tract: a report of two cases. Int J Gynecol Pathol 14:344–351PubMedCrossRefGoogle Scholar
  169. 169.
    Hales HA, Peterson CM et al (1992) Leiomyomatosis peritonealis disseminata treated with a gonadotropin- releasing hormone agonist. Am J Obstet Gynecol 167:515–516PubMedGoogle Scholar
  170. 170.
    Hall KL, Teneriello MG et al (1997) Analysis of Ki-ras, p53, and MDM2 genes in uterine leiomyomas and leiomyosarcomas. Gynecol Oncol 65:330–335PubMedCrossRefGoogle Scholar
  171. 171.
    Han HS, Park IA et al (1998) The clear cell variant of epithelioid intravenous leiomyomatosis of the uterus: report of a case. Pathol Int 48(11):892–896PubMedCrossRefGoogle Scholar
  172. 172.
    Harris NL, Scully RE (1984) Malignant lymphoma and granulocytic sarcoma of the uterus and vagina. A clinicopathologic analysis of 27 cases. Cancer 53:2530–2545PubMedCrossRefGoogle Scholar
  173. 173.
    Hashimoto K, Azuma C et al (1995) Clonal determination of uterine leiomyomas by analyzing differential inactivation of the X-chromosome-linked phosphoglycerokinase gene. Gynecol Obstet Investig 40:204–208CrossRefGoogle Scholar
  174. 174.
    Hattab EM, Allam-Nandyala P et al (1999) The stromal component of large endometrial polyps. Int J Gynecol Pathol 18(4):332–337PubMedCrossRefGoogle Scholar
  175. 175.
    Hawkins WG, Hoos A et al (2001) Clinicopathologic analysis of patients with adult rhabdomyosarcoma. Cancer 91(4):794–803PubMedCrossRefGoogle Scholar
  176. 176.
    Heerema-McKenney A, Wijnaendts LC et al (2008) Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype. Am J Surg Pathol 32(10):1513–1522PubMedCrossRefGoogle Scholar
  177. 177.
    Hendrickson MR, Scheithauer BW (1986) Primitive neuroectodermal tumor of the endometrium: report of two cases, one with electron microscopic observations. Int J Gynecol Pathol 5:249–259PubMedCrossRefGoogle Scholar
  178. 178.
    Hensley ML, Maki R et al (2002) Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol 20(12):2824–2831PubMedCrossRefGoogle Scholar
  179. 179.
    Hillard JB, Malpica A et al (2004) Conservative management of a uterine tumor resembling an ovarian sex cord-stromal tumor. Gynecol Oncol 92(1):347–352PubMedCrossRefGoogle Scholar
  180. 180.
    Hilsenbeck SG, Allred DC (1992) Improved methods of estimating mitotic activity in solid tumors. Hum Pathol 23(6):601–602PubMedCrossRefGoogle Scholar
  181. 181.
    Hirschfield L, Kahn LB et al (1986) Mullerian adenosarcoma with ovarian sex cord-like differentiation. A light- and electron-microscopic study. Cancer 57:1197–1200PubMedCrossRefGoogle Scholar
  182. 182.
    Horie Y, Ikawa S et al (1995) Lipoadenofibroma of the uterine corpus: report of a new variant of adenofibroma (benign mullerian mixed tumor). Arch Pathol Lab Med 119:274–276PubMedGoogle Scholar
  183. 183.
    Hornback NB, Omura G et al (1986) Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma. Int J Radiat Oncol Biol Phys 12(12):2127–2130PubMedCrossRefGoogle Scholar
  184. 184.
    Hornick JL, Fletcher CD (2008) Sclerosing PEComa: clinicopathologic analysis of a distinctive variant with a predilection for the retroperitoneum. Am J Surg Pathol 32(4):493–501PubMedCrossRefGoogle Scholar
  185. 185.
    Horstmann JP, Pietra GG et al (1977) Spontaneous regression of pulmonary leiomyomas during pregnancy. Cancer 39:314–321PubMedCrossRefGoogle Scholar
  186. 186.
    Houghton JP, McCluggage WG (2007) Embryonal rhabdomyosarcoma of the cervix with focal pleomorphic areas. J Clin Pathol 60(1):88–89PubMedCrossRefGoogle Scholar
  187. 187.
    Hrzenjak A, Moinfar F et al (2005) JAZF1/JJAZ1 gene fusion in endometrial stromal sarcomas: molecular analysis by reverse transcriptase-polymerase chain reaction optimized for paraffin-embedded tissue. J Mol Diagn 7(3):388–395PubMedCrossRefGoogle Scholar
  188. 188.
    Hrzenjak A, Tippl M et al (2004) Inverse correlation of secreted frizzled-related protein 4 and beta-catenin expression in endometrial stromal sarcomas. J Pathol 204(1):19–27PubMedCrossRefGoogle Scholar
  189. 189.
    Huang HY, Ladanyi M et al (2004) Molecular detection of JAZF1-JJAZ1 gene fusion in endometrial stromal neoplasms with classic and variant histology: evidence for genetic heterogeneity. Am J Surg Pathol 28(2):224–232PubMedCrossRefGoogle Scholar
  190. 190.
    Hurrell DP, McCluggage WG (2005) Uterine leiomyosarcoma with HMB45+ clear cell areas: report of two cases. Histopathology 47(5):540–542PubMedCrossRefGoogle Scholar
  191. 191.
    Hurrell DP, McCluggage WG (2007) Uterine tumour resembling ovarian sex cord tumour is an immunohistochemically polyphenotypic neoplasm which exhibits coexpression of epithelial, myoid and sex cord markers. J Clin Pathol 60(10):1148–1154PubMedCrossRefGoogle Scholar
  192. 192.
    Hyde KE, Geisinger KR et al (1989) The clear-cell variant of uterine epithelioid leiomyoma. An immunohistologic and ultrastructural study. Arch Pathol Lab Med 113:551–553PubMedGoogle Scholar
  193. 193.
    Inoue M, Fukuda H et al (1995) Adenosarcomas originating from sites other than uterine endometrium. Int J Gynaecol Obstet 48:299–306PubMedCrossRefGoogle Scholar
  194. 194.
    Ip PP, Cheung AN et al (2009) Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases. Am J Surg Pathol 33(7):992–1005PubMedCrossRefGoogle Scholar
  195. 195.
    Irving JA, Carinelli S et al (2006) Uterine tumors resembling ovarian sex cord tumors are polyphenotypic neoplasms with true sex cord differentiation. Mod Pathol 19(1):17–24PubMedCrossRefGoogle Scholar
  196. 196.
    Ito H, Sasaki N et al (1986) Bizarre leiomyoblastoma of the cervix uteri. Immunohistochemical and ultrastructural study. Acta Pathol Jpn 36:1737–1745PubMedGoogle Scholar
  197. 197.
    Jautzke G, Muller-Ruchholtz E et al (1996) Immunohistological detection of estrogen and progesterone receptors in multiple and well differentiated leiomyomatous lung tumors in women with uterine leiomyomas (so-called benign metastasizing leiomyomas). A report on 5 cases. Pathol Res Pract 192:215–223PubMedCrossRefGoogle Scholar
  198. 198.
    Jones MW, Lefkowitz M (1995) Adenosarcoma of the uterine cervix: a clinicopathological study of 12 cases. Int J Gynecol Pathol 14:223–229PubMedCrossRefGoogle Scholar
  199. 199.
    Jones MW, Norris HJ (1995) Clinicopathologic study of 28 uterine leiomyosarcomas with metastasis. Int J Gynecol Pathol 14:243–249PubMedCrossRefGoogle Scholar
  200. 200.
    Joshi D, Anderson JR et al (2004) Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. Pediatr Blood Cancer 42(1):64–73PubMedCrossRefGoogle Scholar
  201. 201.
    Jung CK, Jung JH et al (2008) Diagnostic use of nuclear beta-catenin expression for the assessment of endometrial stromal tumors. Mod Pathol 21(6):756–763PubMedCrossRefGoogle Scholar
  202. 202.
    Jung WY, Shin BK et al (2002) Uterine adenomyoma with uterus-like features: a report of two cases. Int J Surg Pathol 10(2):163–166PubMedCrossRefGoogle Scholar
  203. 203.
    Kairi-Vassilatou E, Kontogianni K et al (2004) A clinicopathological study of the relationship between adenomyosis and other hormone-dependent uterine lesions. Eur J Gynaecol Oncol 25(2):222–224PubMedGoogle Scholar
  204. 204.
    Kaku T, Silverberg SG et al (1992) Adenosarcoma of the uterus: a Gynecologic Oncology Group clinicopathologic study of 31 cases. Int J Gynecol Pathol 11:75–88PubMedCrossRefGoogle Scholar
  205. 205.
    Kalir T, Goldstein M et al (1998) Morphometric and electron-microscopic analyses of the effects of gonadotropin-releasing hormone agonists on uterine leiomyomas. Arch Pathol Lab Med 122(5):442–446PubMedGoogle Scholar
  206. 206.
    Kaminski PF, Tavassoli FA (1984) Plexiform tumorlet: a clinical and pathologic study of 15 cases with ultrastructural observations. Int J Gynecol Pathol 3:124–134PubMedCrossRefGoogle Scholar
  207. 207.
    Kapadia SB, Krause JR et al (1978) Granulocytic sarcoma of the uterus. Cancer 41:687–691PubMedCrossRefGoogle Scholar
  208. 208.
    Karpf EF, Poetsch B et al (2007) Endometrial stromal nodule embedded into term placenta. APMIS 115(11):1302–1305PubMedCrossRefGoogle Scholar
  209. 209.
    Kasashima S, Minato H et al (2007) Alveolar soft part sarcoma of the endometrium with expression of CD10 and hormone receptors. APMIS 115(7):861–865PubMedCrossRefGoogle Scholar
  210. 210.
    Katsanis WA, O’Connor DM et al (1998) Endometrial stromal sarcoma involving the placenta. Ann Diagn Pathol 2(5):301–305PubMedCrossRefGoogle Scholar
  211. 211.
    Kawaguchi K, Fujii S et al (1989) Mitotic activity in uterine leiomyomas during the menstrual cycle. Am J Obstet Gynecol 160:637–641PubMedGoogle Scholar
  212. 212.
    Kempson RL, Hendrickson MR (2000) Smooth muscle, endometrial stromal, and mixed Mullerian tumors of the uterus. Mod Pathol 13(3):328–342PubMedCrossRefGoogle Scholar
  213. 213.
    Kerner H, Lichtig C (1993) Mullerian adenosarcoma presenting as cervical polyps: a report of seven cases and review of the literature. Obstet Gynecol 81:655–659PubMedGoogle Scholar
  214. 214.
    Kim KR, Jun SY et al (2005) Endometrial stromal tumor with limited infiltration and probable extrauterine metastasis: report of a case. Ann Diagn Pathol 9(1):57–60PubMedCrossRefGoogle Scholar
  215. 215.
    Kim WY, Lee JW et al (2008) Low-grade endometrial stromal sarcoma: a single center's experience with 22 cases. Int J Gynecol Cancer 18(5):1084–1089PubMedCrossRefGoogle Scholar
  216. 216.
    King ME, Dickersin GR et al (1982) Myxoid leiomyosarcoma of the uterus: a report of six cases. Am J Surg Pathol 6:589–598PubMedCrossRefGoogle Scholar
  217. 217.
    Kjerulff KH, Langenberg P et al (1996) Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. J Reprod Med 41(7):483–490PubMedGoogle Scholar
  218. 218.
    Klein WM, Kurman RJ (2003) Lack of expression of c-kit protein (CD117) in mesenchymal tumors of the uterus and ovary. Int J Gynecol Pathol 22(2):181–184PubMedCrossRefGoogle Scholar
  219. 219.
    Kokawa K, Yamoto M et al (2002) Postmenopausal intravenous lelomyomatosis with high levels of estradiol and estrogen receptor. Obstet Gynecol 100(5 PT 2):1124–1126PubMedCrossRefGoogle Scholar
  220. 220.
    Kondi-Paphitis A, Smyrniotis B et al (1998) Stromal sarcoma arising on endometriosis. A clinicopathological and immunohistochemical study of 4 cases. Eur J Gynaecol Oncol 19(6):588–590PubMedGoogle Scholar
  221. 221.
    Koontz JI, Soreng AL et al (2001) Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci USA 98(11):6348–6353PubMedCrossRefGoogle Scholar
  222. 222.
    Kosari F, Daneshbod Y et al (2005) Lymphomas of the female genital tract: a study of 186 cases and review of the literature. Am J Surg Pathol 29(11):1512–1520PubMedCrossRefGoogle Scholar
  223. 223.
    Krauss K, Bachmann C et al (2007) Management of late recurrence of a low-grade endometrial stromal sarcoma (LGESS): treatment with letrozole. Anticancer Res 27(5B):3477–3480PubMedGoogle Scholar
  224. 224.
    Krishnamurthy S, Jungbluth AA et al (1998) Uterine tumors resembling ovarian sex-cord tumors have an immunophenotype consistent with true sex-cord differentiation. Am J Surg Pathol 22(9):1078–1082PubMedCrossRefGoogle Scholar
  225. 225.
    Krivak TC, Seidman JD et al (2001) Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival. Gynecol Oncol 83(1):89–94PubMedCrossRefGoogle Scholar
  226. 226.
    Kunzel KE, Mills NZ et al (1993) Myxoid leiomyosarcoma of the uterus. Gynecol Oncol 48:277–280PubMedCrossRefGoogle Scholar
  227. 227.
    Kurihara S, Oda Y et al (2008) Endometrial stromal sarcomas and related high-grade sarcomas: immunohistochemical and molecular genetic study of 31 cases. Am J Surg Pathol 32(8):1228–1238PubMedCrossRefGoogle Scholar
  228. 228.
    Kurman RJ, Norris HJ (1976) Mesenchymal tumors of the uterus. VI. Epithelioid smooth muscle tumors including leiomyoblastoma and clear cell leiomyoma: a clinical and pathological analysis of 26 cases. Cancer 37:1853–1865PubMedCrossRefGoogle Scholar
  229. 229.
    Lack EE, Bitterman P et al (1991) Mullerian adenosarcoma of the uterus with pure angiosarcoma: case report. Hum Pathol 22:1289–1291PubMedCrossRefGoogle Scholar
  230. 230.
    Ladanyi M, Lui MY et al (2001) The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene 20(1):48–57PubMedCrossRefGoogle Scholar
  231. 231.
    Lai FM, Wong FW et al (1991) Diffuse uterine leiomyomatosis with hemorrhage. Arch Pathol Lab Med 115:834–837PubMedGoogle Scholar
  232. 232.
    Langlois PL (1970) The size of the normal uterus. J Reprod Med 4:220–228PubMedGoogle Scholar
  233. 233.
    Larson B, Silfversward C et al (1990) Prognostic factors in uterine leiomyosarcoma. A clinical and histopathological study of 143 cases. The Radiumhemmet series 1936–1981. Acta Oncol 29:185–191PubMedCrossRefGoogle Scholar
  234. 234.
    Lawrence B, Perez-Atayde A et al (2000) TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol 157(2):377–384PubMedCrossRefGoogle Scholar
  235. 235.
    Layfield LJ, Liu K et al (2000) Uterine smooth muscle tumors – Utility of classification by proliferation, ploidy, and prognostic markers versus traditional histopathology. Arch Pathol Lab Med 124(2):221–227PubMedGoogle Scholar
  236. 236.
    Leath CA III, Huh WK et al (2007) A multi-institutional review of outcomes of endometrial stromal sarcoma. Gynecol Oncol 105(3):630–634PubMedCrossRefGoogle Scholar
  237. 237.
    Lee HJ, Choi J et al (2008) Pulmonary benign metastasizing leiomyoma associated with intravenous leiomyomatosis of the uterus: clinical behavior and genomic changes supporting a transportation theory. Int J Gynecol Pathol 27(3):340–345PubMedCrossRefGoogle Scholar
  238. 238.
    Leibsohn S, d’Ablaing G et al (1990) Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. Am J Obstet Gynecol 162:968–974PubMedGoogle Scholar
  239. 239.
    Leiser AL, Anderson SE et al (2006) Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma. Gynecol Oncol 101(1):86–91PubMedCrossRefGoogle Scholar
  240. 240.
    Leitao MM, Sonoda Y et al (2003) Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus. Gynecol Oncol 91(1):209–212PubMedCrossRefGoogle Scholar
  241. 241.
    Leitao MM, Soslow RA et al (2004) Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer 101(6):1455–1462PubMedCrossRefGoogle Scholar
  242. 242.
    Lerwill MF, Sung R et al (2004) Smooth muscle tumors of the ovary: a clinicopathologic study of 54 cases emphasizing prognostic criteria, histologic variants, and differential diagnosis. Am J Surg Pathol 28(11):1436–1451PubMedCrossRefGoogle Scholar
  243. 243.
    Leunen M, Breugelmans M et al (2004) Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole. Gynecol Oncol 95(3):769–771PubMedCrossRefGoogle Scholar
  244. 244.
    Leuschner I, Harms D et al (2001) Rhabdomyosarcoma of the urinary bladder and vagina. A clinicopathologic study with emphasis on recurrent disease: a report from the Kiel pediatric tumor registry and the German CWS study. Am J Surg Pathol 25(7):856–864PubMedCrossRefGoogle Scholar
  245. 245.
    Levenback C, Rubin SC et al (1992) Resection of pulmonary metastases from uterine sarcomas. Gynecol Oncol 45:202–205PubMedCrossRefGoogle Scholar
  246. 246.
    LevGur M, Abadi MA et al (2000) Adenomyosis: Symptoms, histology, and pregnancy terminations. Obstet Gynecol 95(5):688–691PubMedCrossRefGoogle Scholar
  247. 247.
    Li AJ, Giuntoli RL et al (2005) Ovarian preservation in stage I low-grade endometrial stromal sarcomas. Obstet Gynecol 106(6):1304–1308PubMedCrossRefGoogle Scholar
  248. 248.
    Li N, Wu LY et al (2008) Treatment options in stage I endometrial stromal sarcoma: a retrospective analysis of 53 cases. Gynecol Oncol 108(2):306–311PubMedCrossRefGoogle Scholar
  249. 249.
    Lillemoe TJ, Perrone T et al (1991) Myogenous phenotype of epithelial-like areas in endometrial stromal sarcomas. Arch Pathol Lab Med 115:215–219PubMedGoogle Scholar
  250. 250.
    Little DJ, Ballo MT et al (2002) Adult rhabdomyosarcoma – Outcome following multimodality treatment. Cancer 95(2):377–388PubMedCrossRefGoogle Scholar
  251. 251.
    Lloreta J, Prat J (1992) Endometrial stromal nodule with smooth and skeletal muscle components simulating stromal sarcoma. Int J Gynecol Pathol 11(4):293–298PubMedCrossRefGoogle Scholar
  252. 252.
    Lo KW, Yu MY et al (2008) Low-grade endometrial stromal sarcoma with florid intravenous component. Gynecol Obstet Invest 66(1):8–11PubMedCrossRefGoogle Scholar
  253. 253.
    Lobel MK, Somasundaram P et al (2006) The genetic heterogeneity of uterine leiomyomata. Obstet Gynecol Clin N Am 33(1):13–39CrossRefGoogle Scholar
  254. 254.
    Longacre TA, Hendrickson MR et al (1997) Predicting clinical outcome for uterine smooth muscle neoplasms with a reasonable degree of certainty. Adv Anat Pathol 4(2):95–104CrossRefGoogle Scholar
  255. 255.
    Lotgering FK, Pijpers L et al (1989) Pregnancy in a patient with diffuse cavernous hemangioma of the uterus. Am J Obstet Gynecol 160:628–630PubMedGoogle Scholar
  256. 256.
    Mahadeva R, Stewart S et al (1999) Metastatic endometrial stromal sarcoma masquerading as pulmonary lymphangioleiomyomatosis. J Clin Pathol 52(2):147–148PubMedCrossRefGoogle Scholar
  257. 257.
    Majmudar B, Ghanee N et al (1998) Uterine arteriovenous malformation necessitating hysterectomy with bilateral salpingo-oophorectomy in a young pregnant patient. Arch Pathol Lab Med 122(9):842–845PubMedGoogle Scholar
  258. 258.
    Major FJ, Blessing JA et al (1993) Prognostic factors in early-stage uterine sarcoma: a gynecologic oncology group study. Cancer 71(Suppl):1702–1709PubMedCrossRefGoogle Scholar
  259. 259.
    Maluf HM, Gersell DJ (1994) Uterine leiomyomas with high content of mast cells. Arch Pathol Lab Med 118:712–714PubMedGoogle Scholar
  260. 260.
    Manoharan M, Azmi MA et al (2007) Mullerian adenosarcoma of uterine cervix: report of three cases and review of literature. Gynecol Oncol 105(1):256–260PubMedCrossRefGoogle Scholar
  261. 261.
    Marsh EE, Bulun SE (2006) Steroid hormones and leiomyomas. Obstet Gynecol Clin N Am 33(1):59–67CrossRefGoogle Scholar
  262. 262.
    Marshall RJ, Braye SG et al (1986) Leiomyosarcoma of the uterus with giant cells resembling osteoclasts. Int J Gynecol Pathol 5:260–268PubMedCrossRefGoogle Scholar
  263. 263.
    Marshburn PB, Matthews ML et al (2006) Uterine artery embolization as a treatment option for uterine myomas. Obstet Gynecol Clin N Am 33(1):125–144CrossRefGoogle Scholar
  264. 264.
    Martelli H, Oberlin O et al (1999) Conservative treatment for girls with nonmetastatic rhabdomyosarcoma of the genital tract: a report from the Study Committee of the International Society of Pediatric Oncology. J Clin Oncol 17(7):2117–2122PubMedGoogle Scholar
  265. 265.
    Martignoni G, Pea M et al (2008) PEComas: the past, the present and the future. Virchows Archiv 452(2):119–132PubMedCrossRefGoogle Scholar
  266. 266.
    Martin-Reay DG, Christ ML et al (1991) Uterine leiomyoma with skeletal muscle differentiation. Report of a case. Am J Clin Pathol 96(3):344–347PubMedGoogle Scholar
  267. 267.
    Mashal RD, Fejzo ML et al (1994) Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata. Genes Chromosom Cancer 11(1):1–6PubMedCrossRefGoogle Scholar
  268. 268.
    Mayerhofer K, Obermair A et al (1999) Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol 74(2):196–201PubMedCrossRefGoogle Scholar
  269. 269.
    Mazur MT, Kraus FT (1980) Histogenesis of morphologic variations in tumors of the uterine wall. Am J Surg Pathol 4:59–74PubMedGoogle Scholar
  270. 270.
    Mazur MT, Priest JB (1986) Clear cell leiomyoma (leiomyoblastoma) of the uterus: ultrastructural observations. Ultrastruct Pathol 10:249–255PubMedCrossRefGoogle Scholar
  271. 271.
    McCluggage WG, Alderdice JM et al (1999) Polypoid uterine lesions mimicking endometrial stromal sarcoma. J Clin Pathol 52(7):543–546PubMedCrossRefGoogle Scholar
  272. 272.
    McCluggage WG, Cromie AJ et al (2001) Uterine endometrial stromal sarcoma with smooth muscle and glandular differentiation. J Clin Pathol 54(6):481–483PubMedCrossRefGoogle Scholar
  273. 273.
    McCluggage WG, Date A et al (1996) Endometrial stromal sarcoma with sex cord-like areas and focal rhabdoid differentiation. Histopathology 29(4):369–374PubMedCrossRefGoogle Scholar
  274. 274.
    McCluggage WG, Ellis PK et al (2000) Pathologic features of uterine leiomyomas following uterine artery embolization. Int J Gynecol Pathol 19(4):342–347PubMedCrossRefGoogle Scholar
  275. 275.
    McCluggage WG, Ganesan R et al (2009) Endometrial stromal sarcomas with extensive endometrioid glandular differentiation: report of a series with emphasis on the potential for misdiagnosis and discussion of the differential diagnosis. Histopathology 54(3):365–373PubMedCrossRefGoogle Scholar
  276. 276.
    McCluggage WG, Lioe TF et al (2002) Rhabdomyosarcoma of the uterus: report of two cases, including one of the spindle cell variant. Int J Gynecol Cancer 12(1):128–132PubMedCrossRefGoogle Scholar
  277. 277.
    McCluggage WG, Sumathi VP et al (2001) CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms. Histopathology 39(3):273–278PubMedCrossRefGoogle Scholar
  278. 278.
    Mesia AF, Williams FS et al (1998) Aborted leiomyosarcoma after treatment with leuprolide acetate. Obstet Gynecol 92(4 Pt 2):664–666PubMedCrossRefGoogle Scholar
  279. 279.
    Micci F, Heim S (2007) Pathogenetic mechanisms in endometrial stromal sarcoma. Cytogenet Genome Res 118(2–4):190–195PubMedCrossRefGoogle Scholar
  280. 280.
    Micci F, Panagopoulos I et al (2006) Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma. Cancer Res 66(1):107–112PubMedCrossRefGoogle Scholar
  281. 281.
    Mikami Y, Hata S et al (2002) Expression of CD10 in malignant Mullerian mixed tumors and adenosarcomas: an immunohistochemical study. Mod Pathol 15(9):923–930PubMedCrossRefGoogle Scholar
  282. 282.
    Miller KN, McClure SP (1992) Papillary adenofibroma of the uterus: report of a case involved by adenocarcinoma and review of the literature. Am J Clin Pathol 97:806–809PubMedGoogle Scholar
  283. 283.
    Milne DS, Hinshaw K et al (1990) Primary angiosarcoma of the uterus: a case report. Histopathology 16:203–205PubMedCrossRefGoogle Scholar
  284. 284.
    Minassian SS, Frangipane W et al (1986) Leiomyomatosis peritonealis disseminata. A case report and literature review. J Reprod Med 31:997–1000PubMedGoogle Scholar
  285. 285.
    Mittal K, Demopoulos RI (2001) MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors. Hum Pathol 32(9):984–987PubMedCrossRefGoogle Scholar
  286. 286.
    Mittal K, Popiolek D et al (2000) Uterine myxoid leiomyosarcoma within a leiomyoma. Hum Pathol 31(3):398–400PubMedCrossRefGoogle Scholar
  287. 287.
    Moinfar F, Azodi M et al (2007) Uterine sarcomas. Pathology 39(1):55–71PubMedCrossRefGoogle Scholar
  288. 288.
    Moinfar F, Regitnig P et al (2004) Expression of androgen receptors in benign and malignant endometrial stromal neoplasms. Virchows Archiv 444(5):410–414PubMedCrossRefGoogle Scholar
  289. 289.
    Morotti RA, Nicol KK et al (2006) An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children’s oncology group experience. Am J Surg Pathol 30(8):962–968PubMedCrossRefGoogle Scholar
  290. 290.
    Mourits MJE, Hollema H et al (1998) Adenosarcoma of the uterus following tamoxifen treatment for breast cancer. Int J Gynecol Cancer 8:168–171CrossRefGoogle Scholar
  291. 291.
    Mulvany NJ, Ostor AG et al (1995) Diffuse leiomyomatosis of the uterus. Histopathology 27:175–179PubMedCrossRefGoogle Scholar
  292. 292.
    Mulvany NJ, Slavin JL et al (1994) Intravenous leiomyomatosis of the uterus: a clinicopathologic study of 22 cases. Int J Gynecol Pathol 13:1–9PubMedCrossRefGoogle Scholar
  293. 293.
    Murray SK, Clement PB et al (2005) Endometrioid carcinomas of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features: a report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms. Am J Surg Pathol 29(2):157–166PubMedCrossRefGoogle Scholar
  294. 294.
    Myles JL, Hart WR (1985) Apoplectic leiomyomas of the uterus. A clinicopathologic study of five distinctive hemorrhagic leiomyomas associated with oral contraceptive usage. Am J Surg Pathol 9:798–805PubMedCrossRefGoogle Scholar
  295. 295.
    Nakayama M, Mitsuhashi T et al (2006) Immunohistochemical evaluation of KIT expression in sarcomas of the gynecologic region. Int J Gynecol Pathol 25(1):70–76PubMedCrossRefGoogle Scholar
  296. 296.
    Namizato CS, Muriel-Cueto P et al (2008) Chondrosarcoma of the uterus: case report and literature review. Arch Gynecol Obstet 278(4):369–372PubMedCrossRefGoogle Scholar
  297. 297.
    Nascimento AF, Hirsch MS et al (2003) The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis. Mod Pathol 16(1):22–27PubMedCrossRefGoogle Scholar
  298. 298.
    Ng TL, Gown AM et al (2005) Nuclear beta-catenin in mesenchymal tumors. Mod Pathol 18(1):68–74PubMedCrossRefGoogle Scholar
  299. 299.
    Nielsen GP, Oliva E et al (1995) Alveolar soft-part sarcoma of the female genital tract: a report of nine cases and review of the literature. Int J Gynecol Pathol 14:283–292PubMedCrossRefGoogle Scholar
  300. 300.
    Nogales FF, Isaac MA et al (2002) Adenomatoid tumors of the uterus: an analysis of 60 cases. Int J Gynecol Pathol 21(1):34–40PubMedCrossRefGoogle Scholar
  301. 301.
    Nogales FF, Matilla A et al (1978) Leiomyomatosis peritonealis disseminata: an ultrastructural study. Am J Clin Pathol 699:452–457Google Scholar
  302. 302.
    Nogales FF, Navarro N et al (1987) Uterine intravascular leiomyomatosis: an update and report of seven cases. Int J Gynecol Pathol 6:331–339PubMedCrossRefGoogle Scholar
  303. 303.
    Nogales FF, Stolnicu S et al (2009) Retiform uterine tumors resembling ovarian sex cord tumors. A comparative immunohistochemical study with retiform structures of the female genital tract. Histopathology 54(4):471–477PubMedCrossRefGoogle Scholar
  304. 304.
    Nola M, Babic D et al (1996) Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus. Cancer 78(12):2543–2550PubMedCrossRefGoogle Scholar
  305. 305.
    Nordal RR, Kristensen GB et al (1995) The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma. Acta Oncol 34:797–802PubMedCrossRefGoogle Scholar
  306. 306.
    Norris HJ, Hilliard GD et al (1988) Hemorrhagic cellular leiomyomas (“apoplectic leiomyoma”) of the uterus associated with pregnancy and oral contraceptives. Int J Gynecol Pathol 7:212–224PubMedCrossRefGoogle Scholar
  307. 307.
    Norris HJ, Parmley T (1975) Mesenchymal tumors of the uterus. V. Intravenous leiomyomatosis. A clinical and pathologic study of 14 cases. Cancer 36:2164–2178PubMedCrossRefGoogle Scholar
  308. 308.
    Nucci MR, Harburger D et al (2007) Molecular analysis of the JAZF1-JJAZ1 gene fusion by RT-PCR and fluorescence in situ hybridization in endometrial stromal neoplasms. Am J Surg Pathol 31(1):65–70PubMedCrossRefGoogle Scholar
  309. 309.
    Nucci MR, O’Connell JT et al (2001) h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors. Am J Surg Pathol 25(4):455–463PubMedCrossRefGoogle Scholar
  310. 310.
    Nunez-Alonso C, Battifora HA (1979) Plexiform tumors of the uterus: ultrastructural study. Cancer 44:1707–1714PubMedCrossRefGoogle Scholar
  311. 311.
    O’Connor DM, Norris HJ (1990) Mitotically active leiomyomas of the uterus. Hum Pathol 21:223–227PubMedCrossRefGoogle Scholar
  312. 312.
    O’Leary TJ, Steffes MW (1996) Can you count on the mitotic index? Hum Pathol 27:147–151PubMedCrossRefGoogle Scholar
  313. 313.
    O’Neill CJ, McBride HA et al (2007) Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumors of uncertain malignant potential. Histopathology 50(7):851–858PubMedCrossRefGoogle Scholar
  314. 314.
    Oda Y, Nakanishi I et al (1984) Intramural mullerian adenosarcoma of the uterus with adenomyosis. Arch Pathol Lab Med 108(10):798–801PubMedGoogle Scholar
  315. 315.
    Ohta Y, Suzuki T et al (2003) Low-grade endometrial stromal sarcoma with an extensive epithelial-like element. Pathol Int 53(4):246–251PubMedCrossRefGoogle Scholar
  316. 316.
    Oliva E, Clement PB et al (2002) Epithelioid endometrial and endometrioid stromal tumors: a report of four cases emphasizing their distinction from epithelioid smooth muscle tumors and other oxyphilic uterine and extrauterine tumors. Int J Gynecol Pathol 21(1):48–55PubMedCrossRefGoogle Scholar
  317. 317.
    Oliva E, Clement PB et al (1998) Mixed endometrial stromal and smooth muscle tumors of the uterus – A clinicopathologic study of 15 cases. Am J Surg Pathol 22:997–1005PubMedCrossRefGoogle Scholar
  318. 318.
    Oliva E, de Leval L et al (2007) High frequency of JAZF1-JJAZ1 gene fusion in endometrial stromal tumors with smooth muscle differentiation by interphase FISH detection. Am J Surg Pathol 31(8):1277–1284PubMedCrossRefGoogle Scholar
  319. 319.
    Oliva E, Ferry JA et al (1997) Granulocytic sarcoma of the female genital tract: a clinicopathologic study of 11 cases. Am J Surg Pathol 21(10):1156–1165PubMedCrossRefGoogle Scholar
  320. 320.
    Oliva E, Young RH et al (2002) An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus – A study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies. Am J Surg Pathol 26(4):403–412PubMedCrossRefGoogle Scholar
  321. 321.
    Oliva E, Young RH et al (1995) Cellular benign mesenchymal tumors of the uterus: a comparative morphologic and immunohistochemical analysis of 33 highly cellular leiomyomas and six endometrial stromal nodules, two frequently confused tumors. Am J Surg Pathol 19:757–768PubMedCrossRefGoogle Scholar
  322. 322.
    Oliva E, Young RH et al (1999) Myxoid and fibrous endometrial stromal tumors of the uterus: a report of 10 cases. Int J Gynecol Pathol 18(4):310–319PubMedCrossRefGoogle Scholar
  323. 323.
    Ordi J, Stamatakos MD et al (1997) Pure pleomorphic rhabdomyosarcomas of the uterus. Int J Gynecol Pathol 16:369–377PubMedCrossRefGoogle Scholar
  324. 324.
    Orii A, Mori A et al (1998) Mast cells in smooth muscle tumors of the uterus. Int J Gynecol Pathol 17(4):336–342PubMedCrossRefGoogle Scholar
  325. 325.
    Ouyang DW, Economy KE et al (2006) Obstetric complications of fibroids. Obstet Gynecol Clin N Am 33(1):153–169CrossRefGoogle Scholar
  326. 326.
    Park SH, Ro JY et al (2003) Perivascular epithelioid cell tumor of the uterus: immunohistochemical, ultrastructural and molecular study. Pathol Int 53(11):800–805PubMedCrossRefGoogle Scholar
  327. 327.
    Parker WH, Fu YS et al (1994) Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 83:414–418PubMedGoogle Scholar
  328. 328.
    Patai K, Illyes G et al (2006) Uterine leiomyosarcoma with osteoclast like giant cells and long standing systemic symptoms. Gynecol Oncol 102(2):403–405PubMedCrossRefGoogle Scholar
  329. 329.
    Pautier P, Genestie C et al (2000) Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Cancer 88(6):1425–1431PubMedCrossRefGoogle Scholar
  330. 330.
    Payson M, Leppert P et al (2006) Epidemiology of myomas. Obstet Gynecol Clin N Am 33(1):1–11CrossRefGoogle Scholar
  331. 331.
    Pedeutour F, Quade BJ et al (2000) Dysregulation of HMGIC in a uterine lipoleiomyoma with a complex rearrangement including chromosomes 7, 12, and 14. Genes Chromosom Cancer 27(2):209–215PubMedCrossRefGoogle Scholar
  332. 332.
    Pelmus M, Penault-Llorca F et al (2009) Prognostic factors in early-stage leiomyosarcoma of the uterus. Int J Gynecol Cancer 19(3):385–390PubMedCrossRefGoogle Scholar
  333. 333.
    Perrone T, Dehner LP (1988) Prognostically favorable “mitotically active” smooth-muscle tumors of the uterus. A clinicopathologic study of ten cases. Am J Surg Pathol 12:1–8PubMedCrossRefGoogle Scholar
  334. 334.
    Peters WA III, Howard DR et al (1994) Uterine smooth-muscle tumors of uncertain malignant potential. Obstet Gynecol 83:1015–1020PubMedCrossRefGoogle Scholar
  335. 335.
    Pieslor PC, Orenstein JM et al (1979) Ultrastructure of myofibroblasts and decidualized cells in leiomyomatosis peritonealis disseminata. Am J Clin Pathol 72:875–882PubMedGoogle Scholar
  336. 336.
    Pink D, Lindner T et al (2006) Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature. Gynecol Oncol 101(3):464–469PubMedCrossRefGoogle Scholar
  337. 337.
    Policarpio-Nicolas ML, Cathro HP et al (2007) Cytomorphologic features of low-grade endometrial stromal sarcoma. Am J Clin Pathol 128(2):265–271PubMedCrossRefGoogle Scholar
  338. 338.
    Pounder DJ (1982) Fatty tumors of the uterus. J Clin Pathol 35:1380–1383PubMedCrossRefGoogle Scholar
  339. 339.
    Prakash S, Scully RE (1964) Sarcoma-like pseudopregnancy changes in uterine leiomyomas. Report of a case resulting from prolonged norethindrone therapy. Obstet Gynecol 24:106–110PubMedGoogle Scholar
  340. 340.
    Prayson RA, Goldblum JR et al (1997) Epithelioid smooth-muscle tumors of the uterus – A clinicopathologic study of 18 patients. Am J Surg Pathol 21(4):383–391PubMedCrossRefGoogle Scholar
  341. 341.
    Prayson RA, Hart WR (1992) Mitotically active leiomyomas of the uterus. Am J Clin Pathol 97:14–20PubMedGoogle Scholar
  342. 342.
    Quade BJ (1995) Pathology, cytogenetics and molecular biology of uterine leiomyomas and other smooth muscle lesions. Curr Opin Obstet Gynecol 7(1):35–42PubMedGoogle Scholar
  343. 343.
    Quade BJ, McLachlin CM et al (1997) Disseminated peritoneal leiomyomatosis - Clonality analysis by X chromosome inactivation and cytogenetics of a clinically benign smooth muscle proliferation. Am J Pathol 150(6):2153–2166PubMedGoogle Scholar
  344. 344.
    Rabban JT, Zaloudek CJ et al (2005) Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors. Am J Surg Pathol 29(10):1348–1355PubMedCrossRefGoogle Scholar
  345. 345.
    Rackow BW, Arici A (2006) Options for medical treatment of myomas. Obstet Gynecol Clin N Am 33(1):97–113CrossRefGoogle Scholar
  346. 346.
    Radig K, Buhtz P et al (1998) Alveolar soft part sarcoma of the uterine corpus. Report of two cases and review of the literature. Pathol Res Pract 194:59–63PubMedCrossRefGoogle Scholar
  347. 347.
    Raney RB, Anderson JR et al (2001) Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol 23(4):215–220PubMedCrossRefGoogle Scholar
  348. 348.
    Reed NS, Mangioni C et al (2008) Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). Eur J Cancer 44(6):808–818PubMedCrossRefGoogle Scholar
  349. 349.
    Regidor PA, Schmidt M et al (1995) Estrogen and progesterone receptor content of GnRH analogue pretreated and untreated uterine leiomyomata. Eur J Obstet Gynecol Reprod Biol 63:69–73PubMedCrossRefGoogle Scholar
  350. 350.
    Reich O, Regauer S (2007) Hormonal therapy of endometrial stromal sarcoma. Curr Opin Oncol 19(4):347–352PubMedCrossRefGoogle Scholar
  351. 351.
    Reich O, Regauer S et al (2000) Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas. Br J Cancer 82(5):1030–1034PubMedCrossRefGoogle Scholar
  352. 352.
    Rivasi F, Botticelli L et al (2008) Alveolar rhabdomyosarcoma of the uterine cervix. A case report confirmed by FKHR break-apart rearrangement using a fluorescence in situ hybridization probe on paraffin-embedded tissues. Int J Gynecol Pathol 27(3):442–446PubMedCrossRefGoogle Scholar
  353. 353.
    Rizeq MN, Van de Rijn M et al (1994) A comparative immunohistochemical study of uterine smooth muscle neoplasms with emphasis on the epithelioid variant. Hum Pathol 25:671–677PubMedCrossRefGoogle Scholar
  354. 354.
    Roma AA, Yang B et al (2005) TFE3 immunoreactivity in alveolar soft part sarcoma of the uterine cervix: case report. Int J Gynecol Pathol 24(2):131–135PubMedCrossRefGoogle Scholar
  355. 355.
    Rose PG, Piver MS et al (1989) Patterns of metastasis in uterine sarcoma. An autopsy study. Cancer 63:935–938PubMedCrossRefGoogle Scholar
  356. 356.
    Roth E, Taylor HB (1966) Heterotopic cartilage in the uterus. Obstet Gynecol 27:838–844PubMedGoogle Scholar
  357. 357.
    Roth LM, Reed RJ (1999) Dissecting leiomyomas of the uterus other than cotyledonoid dissecting leiomyomas: a report of eight cases. Am J Surg Pathol 23(9):1032–1039PubMedCrossRefGoogle Scholar
  358. 358.
    Roth LM, Reed RJ (2000) Cotyledonoid leiomyoma of the uterus: report of a case. Int J Gynecol Pathol 19(3):272–275PubMedCrossRefGoogle Scholar
  359. 359.
    Roth LM, Reed RJ et al (1996) Cotyledonoid dissecting leiomyoma of the uterus – The Sternberg tumor. Am J Surg Pathol 20(12):1455–1461PubMedCrossRefGoogle Scholar
  360. 360.
    Rush DS, Tan JY et al (2001) h-caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma. Am J Surg Pathol 25(2):253–258PubMedCrossRefGoogle Scholar
  361. 361.
    Rutgers JL, Spong CY et al (1995) Leuprolide acetate treatment and myoma arterial size. Obstet Gynecol 86:386–388PubMedCrossRefGoogle Scholar
  362. 362.
    Sahin AA, Silva EG et al (1989) Endometrial tissue in myometrial vessels not associated with menstruation. Int J Gynecol Pathol 8:139–146PubMedCrossRefGoogle Scholar
  363. 363.
    Sandberg AA (2005) Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyosarcoma. Cancer Genet Cytogenet 161(1):1–19PubMedCrossRefGoogle Scholar
  364. 364.
    Sandberg AA (2007) The cytogenetics and molecular biology of endometrial stromal sarcoma. Cytogenet Genome Res 118(2–4):182–189PubMedCrossRefGoogle Scholar
  365. 365.
    Satoh Y, Ishikawa Y et al (2003) Pulmonary metastases from a low-grade endometrial stromal sarcoma confirmed by chromosome aberration and fluorescence in-situ hybridization approaches: a case of recurrence 13 years after hysterectomy. Virchows Archiv 442(2):173–178PubMedGoogle Scholar
  366. 366.
    Schammel DP, Tavassoli FA (1998) Uterine angiosarcomas – A morphologic and immunohistochemical study of four cases. Am J Surg Pathol 22(2):246–250PubMedCrossRefGoogle Scholar
  367. 367.
    Schilder JM, Hurd WW et al (1999) Hormonal treatment of an endometrial stromal nodule followed by local excision. Obstet Gynecol 93(5 Pt 2):805–807PubMedCrossRefGoogle Scholar
  368. 368.
    Schmid C, Beham A et al (1990) Haematopoiesis in a degenerating uterine leiomyoma. Arch Gynecol Obstet 248(2):81–86PubMedCrossRefGoogle Scholar
  369. 369.
    Schneider D, Halperin R et al (1995) Myxoid leiomyosarcoma of the uterus with unusual malignant histologic pattern – a case report. Gynecol Oncol 59:156–158PubMedCrossRefGoogle Scholar
  370. 370.
    Schwartz EJ, Longacre TA (2004) Adenomatoid tumors of the female and male genital tracts express WT1. Int J Gynecol Pathol 23(2):123–128PubMedCrossRefGoogle Scholar
  371. 371.
    Schwartz LB, Diamond MP et al (1993) Leiomyosarcomas: clinical presentation. Am J Obstet Gynecol 168:180–183PubMedGoogle Scholar
  372. 372.
    Schwartz PE, Kelly MG (2006) Malignant transformation of myomas: myth or reality? Obstet Gynecol Clin N Am 33(1):183–198CrossRefGoogle Scholar
  373. 373.
    Seidman JD, Kjerulff KH (1996) Pathologic findings from the Maryland Women’s Health Study: practice patterns in the diagnosis of adenomyosis. Int J Gynecol Pathol 15:217–221PubMedCrossRefGoogle Scholar
  374. 374.
    Seidman JD, Thomas RM (1993) Multiple plexiform tumorlets of the uterus. Arch Pathol Lab Med 117:1255–1256PubMedGoogle Scholar
  375. 375.
    Seidman JD, Wasserman CS et al (1999) Cluster of uterine mullerian adenosarcoma in the Washington, DC metropolitan area with high incidence of sarcomatous overgrowth. Am J Surg Pathol 23(7):809–814PubMedCrossRefGoogle Scholar
  376. 376.
    Sener AB, Seckin NC et al (1996) The effects of hormone replacement therapy on uterine fibroids in postmenopausal women. Fertil Steril 65(2):354–357PubMedGoogle Scholar
  377. 377.
    Shaw RW (1998) Gonadotrophin hormone-releasing hormone analogue treatment of fibroids. Baillières Clin Obstet Gynaecol 12(2):245–268PubMedCrossRefGoogle Scholar
  378. 378.
    Shintaku M, Fukushima A (2006) Inflammatory myofibroblastic tumor of the uterus with prominent myxoid change. Pathol Int 56(10):625–628PubMedCrossRefGoogle Scholar
  379. 379.
    Silva EG, Bodurka DC et al (2005) A uterine leiomyosarcoma that became positive for HMB45 in the metastasis. Ann Diagn Pathol 9(1):43–45PubMedCrossRefGoogle Scholar
  380. 380.
    Silva EG, Deavers MT et al (2004) Uterine epithelioid leiomyosarcomas with clear cells: reactivity with HMB-45 and the concept of PEComa. Am J Surg Pathol 28(2):244–249PubMedCrossRefGoogle Scholar
  381. 381.
    Silva EG, Tornos C et al (1995) Uterine leiomyosarcoma with clear cell areas. Int J Gynecol Pathol 14:174–178PubMedCrossRefGoogle Scholar
  382. 382.
    Simpson KW, Albores-Saavedra J (2007) HMB-45 reactivity in conventional uterine leiomyosarcomas. Am J Surg Pathol 31(1):95–98PubMedCrossRefGoogle Scholar
  383. 383.
    Sinkre P, Albores-Saavedra J et al (2000) Endometrial endometrioid carcinomas associated with Ewing sarcoma/peripheral primitive neuroectodermal tumor. Int J Gynecol Pathol 19(2):127–132PubMedCrossRefGoogle Scholar
  384. 384.
    Sinkre P, Miller DS et al (2000) Adenomyofibroma of the endometrium with skeletal muscle differentiation. Int J Gynecol Pathol 19(3):280–283PubMedCrossRefGoogle Scholar
  385. 385.
    Siskin GP, Shlansky-Goldberg RD et al (2006) A prospective multicenter comparative study between myomectomy and uterine artery embolization with polyvinyl alcohol microspheres: long-term clinical outcomes in patients with symptomatic uterine fibroids. J Vasc Interv Radiol 17(8):1287–1295PubMedCrossRefGoogle Scholar
  386. 386.
    Skubitz KM, Skubitz AP (2003) Differential gene expression in leiomyosarcoma. Cancer 98(5):1029–1038PubMedCrossRefGoogle Scholar
  387. 387.
    Sorensen JB, Schultze HR et al (1998) Primitive neuroectodermal tumor (PNET) of the uterine cavity. Eur J Obstet Gynecol Reprod Biol 76(2):181–184PubMedCrossRefGoogle Scholar
  388. 388.
    Sorensen PH, Lynch JC et al (2002) PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. J Clin Oncol 20(11):2672–2679PubMedCrossRefGoogle Scholar
  389. 389.
    Sornberger KS, Weremowicz S et al (1999) Expression of HMGIY in three uterine leiomyomata with complex rearrangements of chromosome 6. Cancer Genet Cytogenet 114(1):9–16PubMedCrossRefGoogle Scholar
  390. 390.
    Soslow RA, Ali A et al (2008) Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases. Am J Surg Pathol 32(7):1013–1021PubMedCrossRefGoogle Scholar
  391. 391.
    Sozen I, Arici A (2006) Cellular biology of myomas: interaction of sex steroids with cytokines and growth factors. Obstet Gynecol Clin N Am 33(1):41–58CrossRefGoogle Scholar
  392. 392.
    Spies JB, Ascher SA et al (2001) Uterine artery embolization for leiomyomata. Obstet Gynecol 98(1):29–34PubMedCrossRefGoogle Scholar
  393. 393.
    Sreenan JJ, Prayson RA et al (1996) Histopathologic findings in 107 uterine leiomyomas treated with leuprolide acetate compared with 126 controls. Am J Surg Pathol 20(4):427–432PubMedCrossRefGoogle Scholar
  394. 394.
    Srodon M, Klein WM et al (2003) CD10 immunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis. Am J Surg Pathol 27(6):786–789PubMedCrossRefGoogle Scholar
  395. 395.
    Staats PN, Garcia JJ et al (2009) Uterine tumors resembling ovarian sex cord tumors (UTROSCT) lack the JAZF1-JJAZ1 translocation frequently seen in endometrial stromal tumors. Am J Surg Pathol 33(8):1206–1212. doi:10.1097/PAS.0b013e3181a7b9cfPubMedCrossRefGoogle Scholar
  396. 396.
    Stovall TG, Ling FW et al (1991) A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas. Am J Obstet Gynecol 164:1420–1423PubMedGoogle Scholar
  397. 397.
    Stroh EL, Besa PC et al (1995) Treatment of patients with lymphomas of the uterus or cervix with combination chemotherapy and radiation therapy. Cancer 75:2392–2399PubMedCrossRefGoogle Scholar
  398. 398.
    Su LD, Atayde-Perez A et al (1998) Inflammatory myofibroblastic tumor: cytogenetic evidence supporting clonal origin. Mod Pathol 11:364–368PubMedGoogle Scholar
  399. 399.
    Suginami H, Kaura R et al (1990) Intravenous leiomyomatosis with cardiac extension: successful surgical management and histopathologic study. Obstet Gynecol 76:527–529PubMedGoogle Scholar
  400. 400.
    Sullivan LM, Atkins KA et al (2009) PAX immunoreactivity identifies alveolar rhabdomyosarcoma. Am J Surg Pathol 33(5):775–780PubMedCrossRefGoogle Scholar
  401. 401.
    Sumathi VP, Al-Hussaini M et al (2004) Endometrial stromal neoplasms are immunoreactive with WT-1 antibody. Int J Gynecol Pathol 23(3):241–247PubMedCrossRefGoogle Scholar
  402. 402.
    Sutton G, Blessing J et al (2005) Phase II evaluation of liposomal doxorubicin (Doxil) in recurrent or advanced leiomyosarcoma of the uterus: a Gynecologic Oncology Group study. Gynecol Oncol 96(3):749–752PubMedCrossRefGoogle Scholar
  403. 403.
    Sutton G, Blessing JA et al (1996) Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study. Gynecol Oncol 62:226–229PubMedCrossRefGoogle Scholar
  404. 404.
    Tabata T, Takeshima N et al (1999) Low-grade endometrial stromal sarcoma with cardiovascular involvement – a report of three cases. Gynecol Oncol 75(3):495–498PubMedCrossRefGoogle Scholar
  405. 405.
    Tahlan A, Nanda A et al (2006) Uterine adenomyoma: a clinicopathologic review of 26 cases and a review of the literature. Int J Gynecol Pathol 25(4):361–365PubMedCrossRefGoogle Scholar
  406. 406.
    Tai LH, Tavassoli FA (2002) Endometrial polyps with atypical (bizarre) stromal cells. Am J Surg Pathol 26(4):505–509PubMedCrossRefGoogle Scholar
  407. 407.
    Tallini G, Price FV et al (1993) Epithelioid angiosarcoma arising in uterine leiomyomas. Am J Clin Pathol 100:514–518PubMedGoogle Scholar
  408. 408.
    Tang CK, Toker C et al (1979) Stromomyoma of the uterus. Cancer 43:308–316PubMedCrossRefGoogle Scholar
  409. 409.
    Tavassoli FA, Devilee P et al (2003) Pathology and genetics of tumors of the breast and female genital organs. Lyon, International Agency for Research on CancerGoogle Scholar
  410. 410.
    Tavassoli FA, Norris HJ (1981) Mesenchymal tumors of the uterus. VII. A clinicopathological study of 60 endometrial stromal nodules. Histopathology 5:1–10PubMedCrossRefGoogle Scholar
  411. 411.
    Tavassoli FA, Norris HJ (1982) Peritoneal leiomyomatosis (leiomyomatosis peritonealis disseminata): a clinicopathologic study of 20 cases with ultrastructural observations. Int J Gynecol Pathol 1:59–74PubMedCrossRefGoogle Scholar
  412. 412.
    Tietze L, Guenther K et al (2000) Benign metastasizing leiomyoma: A cytogenetically balanced but clonal disease. Hum Pathol 31(1):126–128PubMedCrossRefGoogle Scholar
  413. 413.
    Tiltman AJ (1985) The effect of progestins on the mitotic activity of uterine fibromyomas. Int J Gynecol Pathol 4:89–96PubMedCrossRefGoogle Scholar
  414. 414.
    Toki T, Shimizu M et al (2002) CD10 is a marker for normal and neoplastic endometrial stromal cells. Int J Gynecol Pathol 21(1):41–47PubMedCrossRefGoogle Scholar
  415. 415.
    Torres VE, Bjornsson J et al (1995) Extrapulmonary lymphangioleiomyomatosis and lymphangiomatous cysts in tuberous sclerosis complex. Mayo Clin Proc 70:641–648PubMedCrossRefGoogle Scholar
  416. 416.
    Tresukosol DR, Kudelka AP et al (1995) Leuprolide acetate and intravascular leiomyomatosis. Obstet Gynecol 86:688–692PubMedCrossRefGoogle Scholar
  417. 417.
    Upadhyaya NB, Doody MC et al (1990) Histopathological changes in leiomyomata treated with leuprolide acetate. Fertil Steril 54:811–814PubMedGoogle Scholar
  418. 418.
    Van Diest PJ, Baak JP et al (1992) Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project. Hum Pathol 23(6):603–607PubMedCrossRefGoogle Scholar
  419. 419.
    Vang R, Kempson RL (2002) Perivascular epithelioid cell tumor (“PEComa”) of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors. Am J Surg Pathol 26(1):1–13PubMedCrossRefGoogle Scholar
  420. 420.
    Vang R, Medeiros LJ et al (2000) Non-Hodgkin’s lymphomas involving the uterus: a clinicopathologic analysis of 26 cases. Mod Pathol 13(1):19–28PubMedCrossRefGoogle Scholar
  421. 421.
    Vang R, Medeiros LJ et al (2001) Uterine leiomyomas with eosinophils: a clinicopathologic study of 3 cases. Int J Gynecol Pathol 20(3):239–243PubMedCrossRefGoogle Scholar
  422. 422.
    Varghese L, Arnesen M et al (2006) Primitive neuroectodermal tumor of the uterus: a case report and review of literature. Int J Gynecol Pathol 25(4):373–377PubMedCrossRefGoogle Scholar
  423. 423.
    Venkatraman L, Elliott H et al (2003) Serous carcinoma arising in an adenofibroma of the endometrium. Int J Gynecol Pathol 22(2):194–197PubMedCrossRefGoogle Scholar
  424. 424.
    Verschraegen CF, Vasuratna A et al (1998) Clinicopathologic analysis of mullerian adenosarcoma: the M.D. Anderson Cancer Center experience. Oncol Rep 5(4):939–944PubMedGoogle Scholar
  425. 425.
    Vitiello D, McCarthy S (2006) Diagnostic imaging of myomas. Obstet Gynecol Clin N Am 33(1):85–95CrossRefGoogle Scholar
  426. 426.
    Viville B, Charnock-Jones DS et al (1997) Distribution of the A and B forms of the progesterone receptor messenger ribonucleic acid and protein in uterine leiomyomata and adjacent myometrium. Hum Reprod 12(4):815–822PubMedCrossRefGoogle Scholar
  427. 427.
    Vollenhoven B (1998) Introduction: the epidemiology of uterine leiomyomas. Baillières Clin Obstet Gynaecol 12(2):169–176PubMedCrossRefGoogle Scholar
  428. 428.
    Vu K, Greenspan DL et al (1998) Cellular proliferation, estrogen receptor, progesterone receptor, and bcl-2 expression in GnRH agonist-treated uterine leiomyomas. Hum Pathol 29(4):359–363PubMedCrossRefGoogle Scholar
  429. 429.
    Wachtel M, Runge T et al (2006) Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry. J Clin Oncol 24(5):816–822PubMedCrossRefGoogle Scholar
  430. 430.
    Wakami K, Tateyama H et al (2005) Solitary fibrous tumor of the uterus producing high-molecular-weight insulin-like growth factor II and associated with hypoglycemia. Int J Gynecol Pathol 24(1):79–84PubMedGoogle Scholar
  431. 431.
    Wallach EE, Vlahos NF (2004) Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol 104(2):393–406PubMedCrossRefGoogle Scholar
  432. 432.
    Wang X, Kumar D et al (2006) Uterine lipoleiomyomas: a clinicopathologic study of 50 cases. Int J Gynecol Pathol 25(3):239–242PubMedCrossRefGoogle Scholar
  433. 433.
    Watanabe K, Suzuki T (2006) Uterine leiomyoma versus leiomyosarcoma: a new attempt at differential diagnosis based on their cellular characteristics. Histopathology 48(5):563–568PubMedCrossRefGoogle Scholar
  434. 434.
    Weichert W, Denkert C et al (2005) Uterine arterial embolization with tris-acryl gelatin microspheres: a histopathologic evaluation. Am J Surg Pathol 29(7):955–961PubMedCrossRefGoogle Scholar
  435. 435.
    Weissman A, Talmon R et al (1993) Cavernous hemangioma of the uterus in a pregnant woman. Obstet Gynecol 81:825–827PubMedGoogle Scholar
  436. 436.
    Witkin GB, Askin FB et al (1987) Angiosarcoma of the uterus: a light microscopic, immunohistochemical, and ultrastructural study. Int J Gynecol Pathol 6:176–184PubMedCrossRefGoogle Scholar
  437. 437.
    Wolff M, Silva F et al (1979) Pulmonary metastases (with admixed epithelial elements) from smooth muscle neoplasms: report of nine cases, including three males. Am J Surg Pathol 3:325–342PubMedCrossRefGoogle Scholar
  438. 438.
    Wolfson AH, Wolfson DJ et al (1994) A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas. Gynecol Oncol 52:56–62PubMedCrossRefGoogle Scholar
  439. 439.
    Wright JD, Seshan VE et al (2008) The role of radiation in improving survival for early-stage carcinosarcoma and leiomyosarcoma. Am J Obstet Gynecol 199(5):536.e1–536.e8CrossRefGoogle Scholar
  440. 440.
    Yamadori I, Kobayashi S et al (1993) Uterine leiomyoma with a focus of fatty and cartilaginous differentiation. Acta Obstet Gynecol Scand 72:307–309PubMedCrossRefGoogle Scholar
  441. 441.
    Yilmaz A, Rush DS et al (2002) Endometrial stromal sarcomas with unusual histologic features: a report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation. Am J Surg Pathol 26(9):1142–1150PubMedCrossRefGoogle Scholar
  442. 442.
    Young RH, Harris NL et al (1985) Lymphoma-like lesions of the lower female genital tract: a report of 16 cases. Int J Gynecol Pathol 4:289–299PubMedCrossRefGoogle Scholar
  443. 443.
    Young RH, Prat J et al (1984) Endometrioid stromal sarcomas of the ovary. A clinicopatholgic analysis of 23 cases. Cancer 53:1143–1155PubMedCrossRefGoogle Scholar
  444. 444.
    Young RH, Silva EG et al (1991) Ovarian and juxtaovarian adenomatoid tumors: a report of six cases. Int J Gynecol Pathol 10:364–372PubMedCrossRefGoogle Scholar
  445. 445.
    Zaloudek CJ, Norris HJ (1981) Adenofibroma and adenosarcoma of the uterus: a clinicopathologic study of 35 cases. Cancer 48:354–366PubMedCrossRefGoogle Scholar
  446. 446.
    Zamecnik M, Sultani K (2007) Meningothelial-like nodules: additional pattern of myoid differentiation in endometrial stromal tumors. Pathol Int 57(9):632–633PubMedCrossRefGoogle Scholar
  447. 447.
    Zhai YL, Kobayashi Y et al (1999) Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas. Int J Gynecol Pathol 18(1):20–28PubMedCrossRefGoogle Scholar
  448. 448.
    Zivanovic O, Leitao MM et al (2009) Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systems. J Clin Oncol 27(12):2066–2072PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Charles J. Zaloudek
    • 1
  • Michael R. Hendrickson
    • 2
  • Robert A. Soslow
    • 3
  1. 1.Department of PathologyUniversity of California, San FranciscoSan FranciscoUSA
  2. 2.Department of Surgical PathologyStanford University Medical CenterStanfordUSA
  3. 3.Department of PathologyMemorial Sloan-Kettering Cancer CenterNew YorkUSA

Personalised recommendations